DK1038001T3 - Konstitutiv ekspression af ikke-infektiöse HIV-lignende partikler - Google Patents

Konstitutiv ekspression af ikke-infektiöse HIV-lignende partikler

Info

Publication number
DK1038001T3
DK1038001T3 DK98960976T DK98960976T DK1038001T3 DK 1038001 T3 DK1038001 T3 DK 1038001T3 DK 98960976 T DK98960976 T DK 98960976T DK 98960976 T DK98960976 T DK 98960976T DK 1038001 T3 DK1038001 T3 DK 1038001T3
Authority
DK
Denmark
Prior art keywords
particles
hiv
constitutive expression
modified
genome
Prior art date
Application number
DK98960976T
Other languages
English (en)
Inventor
Benjamin Rovinski
Fei-Long Yao
Shi Xian Cao
Original Assignee
Sanofi Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25537545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1038001(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd
Application granted granted Critical
Publication of DK1038001T3 publication Critical patent/DK1038001T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98960976T 1997-12-16 1998-12-14 Konstitutiv ekspression af ikke-infektiöse HIV-lignende partikler DK1038001T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/991,773 US6121021A (en) 1997-12-16 1997-12-16 Constitutive expression of non-infectious HIV-like particles

Publications (1)

Publication Number Publication Date
DK1038001T3 true DK1038001T3 (da) 2006-07-10

Family

ID=25537545

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98960976T DK1038001T3 (da) 1997-12-16 1998-12-14 Konstitutiv ekspression af ikke-infektiöse HIV-lignende partikler

Country Status (12)

Country Link
US (2) US6121021A (da)
EP (1) EP1038001B8 (da)
JP (1) JP2004509601A (da)
AT (1) ATE318909T1 (da)
AU (1) AU749174B2 (da)
BR (1) BR9813626A (da)
CA (1) CA2312943C (da)
DE (1) DE69833686T2 (da)
DK (1) DK1038001T3 (da)
ES (1) ES2262250T3 (da)
PT (1) PT1038001E (da)
WO (1) WO1999031250A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080408A (en) * 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
EP1083230A1 (en) * 1999-09-10 2001-03-14 Academisch Medisch Centrum Amsterdam Viral replicons and viruses dependent on inducing agents
US8623379B2 (en) * 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
US20040105871A1 (en) * 2000-03-02 2004-06-03 Robinson Harriet L. Compositions and methods for generating an immune response
EP2388015A1 (en) 2000-03-02 2011-11-23 Emory University DNA expression vectors and methods of use
EP1776961A1 (en) * 2000-04-27 2007-04-25 Sanofi Pasteur Limited Immunizing against HIV infection
ES2282251T3 (es) * 2000-04-27 2007-10-16 Sanofi Pasteur Limited Vacunas contra la infeccion por vih.
US7122180B2 (en) * 2000-10-23 2006-10-17 Children's Medical Center Corporation DNA vectors containing mutated HIV proviruses
DK1372710T3 (da) * 2001-03-08 2010-01-18 Us Gov Health & Human Serv MVA der udtrykker modificeret HIV-kappe-, Gag- og Pol-gener
US20060088909A1 (en) * 2002-05-17 2006-04-27 Compans Richard W Virus-like particles, methods of preparation, and immunogenic compositions
US9045727B2 (en) * 2002-05-17 2015-06-02 Emory University Virus-like particles, methods of preparation, and immunogenic compositions
JP2007505130A (ja) * 2003-09-09 2007-03-08 バイレクシス コーポレイション ヒトにおいてｈｉｖに対する免疫応答を生成するための、レンチウイルスベクターベースのアプローチ
US20090257983A1 (en) * 2008-04-11 2009-10-15 Scheiber Lane Bernard Medical treatment device for treating aids by utilizing modified human immunodeficiency virus virions to insert anti-viral medications into t-helper cells
US20110293694A1 (en) * 2010-05-31 2011-12-01 Scheiber Lane Bernard Quantum unit of inheritance vector therapy method
US20110293693A1 (en) * 2010-05-31 2011-12-01 Scheiber Lane Bernard Quantum unit of inheritance vector therapy
DK2694101T3 (da) 2011-04-06 2017-01-09 Biovaxim Ltd Farmaceutiske sammensætninger til forebyggelse og/eller behandling af en HIV-sygdom hos mennesker

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001230A (en) * 1988-02-18 1991-03-19 Schering Corporation T cell activation markers
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
JPH05501201A (ja) * 1989-10-16 1993-03-11 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 非感染性ｈｉｖ―１粒子およびそれらの使用
JPH05503629A (ja) * 1989-11-20 1993-06-17 オンコーゲン　リミテッド　パートナーシップ 抗ウィルス剤及び免疫原として使用される、非複製組換え製レトロウィルス粒子
DE69111440T2 (de) * 1990-04-03 1996-03-28 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
AU678152B2 (en) * 1992-03-27 1997-05-22 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
US5864027A (en) * 1993-06-07 1999-01-26 Genentech, Inc. HIV envelope polypeptides
CN1111540C (zh) * 1993-06-09 2003-06-18 康诺特实验室有限公司 串联的合成hiv－1肽类
US6080408A (en) * 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
DE69703974T2 (de) * 1996-10-17 2001-07-19 Oxford Biomedica (Uk) Ltd., Oxford Retrovirale vektoren
IL132164A0 (en) * 1997-04-09 2001-03-19 Chang Lung Ji Animal model for evaluation of vaccines
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles

Also Published As

Publication number Publication date
EP1038001B8 (en) 2006-09-13
AU749174B2 (en) 2002-06-20
DE69833686T2 (de) 2006-11-30
US6572863B1 (en) 2003-06-03
WO1999031250A3 (en) 1999-08-19
CA2312943C (en) 2009-02-24
DE69833686D1 (de) 2006-04-27
EP1038001B1 (en) 2006-03-01
CA2312943A1 (en) 1999-06-24
ES2262250T3 (es) 2006-11-16
PT1038001E (pt) 2006-07-31
EP1038001A2 (en) 2000-09-27
JP2004509601A (ja) 2004-04-02
AU1657799A (en) 1999-07-05
US6121021A (en) 2000-09-19
ATE318909T1 (de) 2006-03-15
BR9813626A (pt) 2002-07-23
WO1999031250A2 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
DK1038001T3 (da) Konstitutiv ekspression af ikke-infektiöse HIV-lignende partikler
PL332876A1 (en) Lentoviral vectors
NO983102D0 (no) Uttrykk og forsterkning av sekvenselementer (EASE) for eukaryote ekspresjonssystemer
DK0452484T3 (da) Fremstilling af proteiner ved homolog rekombination
ATE349540T1 (de) Expression der bazillus thuringiensis cry- proteine in pflanzen-plastiden
DK1244805T3 (da) Virale kerneprotein-kationiske lipid-nukleinsyre-frigivelseskomplekser
CA2305013A1 (en) Fusion proteins comprising hiv-1 tat and/or nef proteins
ATE380822T1 (de) Funf-helix protein
WO2000038216A3 (en) High voltage photovoltaic power converter
TR199801933A2 (xx) Biyolojik olarak tolare edilebilen d���k molek�ler polietileniminler.
DK1702979T3 (da) Improved keratinocyte culture and uses thereof
AU5539898A (en) Nucleic acid construct for the cell cycle regulated expression of structural genes
CY1107431T1 (el) Σωματιδια για γoνιδιακη θεραπεια
AU2149099A (en) Pseudo-type retroviral vectors with modifiable surface capsid proteins
TR200001046T2 (tr) Homolog rekombinasyonda pozitif-negatif seçimi.
DK0843731T3 (da) Adenovirusvektorer til genterapi
AU2520595A (en) Virosome-mediated intracellular delivery of therapeutic agents
EA199900144A1 (ru) Способ индуцирования вирусной устойчивости в растении
DE3577994D1 (de) Vergroessernde virale dna-segmente.
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
DK176387D0 (da) Fremgangsmaade til frembringelse af et funktionelt polypeptid i en eukaryot vaertscelle ved anvendelse af en rekombinant dna udtrykkelsesvektor omfattende en bk virusforstaerker
WO2001083822A3 (en) Use of representations of dna for genetic analysis
ATE259421T1 (de) Dna-virus-vektoren und verfahren zu ihrer herstellung
EP1356063B8 (en) Expression of multiple proteins in transgenic plants
DK0988305T3 (da) Fremgangsmåde til fremstilling af 5H,9bH-2a,4a,7,9a-octahydro-tetraazacycloocta[cd]pentalen